Bicarbonate

Bicarbonate

SCHEMBL9521052

O=C(O)O.c1cncc(CCCCCC2CCCCC2)c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 7/20 0.58
LMNA P02545 1/20 0.52
HRH1 P35367 2/20 0.49
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
BMP1 P13497 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL9520584 0.99 TBXAS1 (0.59) TBXAS1LMNAHRH1TDP1L3MBTL1
Bicarbonate SCHEMBL9519855 0.93 TBXAS1 (0.62) TBXAS1HRH1TDP1L3MBTL1
SCHEMBL7407607 0.87 CYP2A6 (0.53) TBXAS1LMNAHRH1TDP1L3MBTL1
SCHEMBL6569542 0.87 CYP2A6 (0.53) TBXAS1LMNAHRH1TDP1L3MBTL1
SCHEMBL7427487 0.86 CYP2A6 (0.54) TBXAS1LMNAHRH1TDP1L3MBTL1
Bicarbonate SCHEMBL9522433 0.83 TBXAS1 (0.81) TBXAS1HRH1TDP1L3MBTL1
SCHEMBL17064309 0.80 CYP2A6 (0.58) TBXAS1HRH1TDP1L3MBTL1
SCHEMBL7392307 0.78 SIGMAR1 (0.64) SIGMAR1
SCHEMBL5087578 0.78 SIGMAR1 (0.64) SIGMAR1
SCHEMBL11020642 0.78 SIGMAR1 (0.64) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299379-B1 PENTADIENAMIDE PAF-ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1993-04-21 EP disclosed
EP-0299379-A1 Pentadienamide PAF-antagonists F. HOFFMANN-LA ROCHE AG (CH) 1989-01-18 EP disclosed